Oaktree Fund Advisors »

Bioxcel Therapeutics shares owned by Oaktree Fund Advisors

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Oaktree Fund Advisors from 13F filings

Historical chart of Oaktree Fund Advisors investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Oaktree Fund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Oaktree Fund Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $110k 43k 2.56
2025-06-30 $78k 43k 1.81

More positions owned by Oaktree Fund Advisors

Anglogold Ashanti Common Stock (AU)
Barrick Mining Corp Common Stock (B)
Itau Unibanco Holding Sa Common Stock (ITUB)
Hdfc Bank Common Stock (HDB)
Grab Holdings Common Stock (GRAB)
Nu Holdings Ltd/cayman Islands Common Stock (NU)
Freeport-mcmoran Common Stock (FCX)
Full Truck Alliance Common Stock (YMM)
XP Common Stock (XP)
Kanzhun Common Stock (BZ)
Ternium Sa Common Stock (TX)
Sea Common Stock (SE)
JBS NV Common Stock (JBS)
Alvotech Sa Common Stock (ALVO)
Jetblue Airways Corp Convertible Bond (Principal)

View all positions for Oaktree Fund Advisors

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
FMR
Vanguard Group
Geode Capital Management
XTX Topco
BlackRock
State Street Corporation
UBS Group
Oaktree Fund Advisors
Northern Trust
Jones Financial Companies, L.L
HighTower Advisors
Foundations Investment Advisors
SLT Holdings

View all funds holding Bioxcel Therapeutics